SpeedWeed

MARCH 9, 2021

ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products – and six more products to follow. Hesse-based Stada, Germany’s fifth largest pharmaceutical company, announced late last year it had entered into an agreement with Canadian firm MediPharm Labs.

Chronic Pain 52

Chronic Pain Business Pharmaceutical Extraction 52

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

JULY 12, 2021

Pure Extracts Inc. Algernon Pharmaceuticals Inc. CSE: MSET) revealed additional preclinical data showing strong efficacy and improved safety in a head-to-head comparison with psilocybin. Weekly Performance: $133.19 (-1.61%). Powered by. CFN Enterprises Inc. OTCQB: CNFN). Top Gainers. CSE: PULL). 0.385 +0.155 (67.39%).

Treatment 66

Treatment Decriminalization Pharmaceutical Data 66

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?Orphan

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

AUGUST 11, 2021

The Licensing Agreement is for the commercialization of a number of Avicanna’s advanced CBD-based topical products under Heritage’s medical cannabis brands (the “Branded Products”) targeting patients registered to purchase medical cannabis in Canada. They are a great strategic fit.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland.

History 52

History Clinical Trials Legalization Research and Development 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. Types of Research. There’s another problem: science communication and literacy.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 6, 2021

Dr. Bankole Johnson was also the founder of NASDAQ listed Adial Pharmaceuticals (NASDAQ: ADIL) and currently serves as its Chief Medical Officer. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Ehave, Inc. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Indeed, the scientific literature regarding CBD and some forms of epilepsy is rich and full of data.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Joint Blog

NOVEMBER 2, 2020

According to a new study published in the Journal of Pharmacy & Pharmaceutical Sciences, using marijuana as an adjunct treatment for Huntington disease (HD) is both effective and safe. The study states that marijuana can improve neurological symptoms and should be recommended to HD patients by their physicians.

Treatment 37

Treatment Sleep Marijuana Patients 37

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. For example, pharmaceutical-grade cannabis is being sold across the fast-evolving retail pharmacy landscape. by the year 2027 , at which point the market could be worth a staggering $33.2

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. Extracting them directly from the plant could also have the risk of unwanted components that might cause psychosis for users.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

The Cannigma

OCTOBER 9, 2021

Varied personal accounts of cannabis consumption causing a wide range of urinary effects have included but are not limited to: being unable to pee while feeling a strong urge to pee, peeing caused by laughter, and multiple sclerosis patients learning their cannabis medication also helps reduce the number of times they have to run to the bathroom.

Cannabinoids 86

Cannabinoids Consumption Patients Cannabis 86

Cannabis Law Report

OCTOBER 15, 2019

The medical cannabis industry is coming to Brazil beyond imports of pharmaceutical-based cannabis medicines. . Brazil is currently a leading importer of pharmaceutical-based cannabis medicine. Pharmaceutical-based cannabis products are not effective for a large number of suffering patients in Brazil.

Pharmaceutical 40

Pharmaceutical Sativa Topical Cultivation 40

Cannabis Law Report

JULY 16, 2019

In July, 2012, he and his wife settled in south Redding, where, at the time, the outdoor cultivation of medical cannabis was legal for qualified patients. Rubin says he frantically called city council members, city staff, anyone who could tell him if the ban truly applied to medical marijuana patients. Although Prop. Under Prop.

Patients 40

Patients Cultivation Cannabis Strains 40

Cannabis Info

MARCH 2, 2019

Epilepsy is usually diagnosed after patients have experienced a series of seizures. However, the most common attempt at treating the condition is through medication, many patients may need to take them for the rest of their life. ” CBD may be easier for patients to access when they opt to start treatment with medical cannabis.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

JULY 24, 2022

The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Nevertheless, the regulatory hurdles for researchers and patients are still extremely high. Psilocybin was first extracted and identified in 1958. percent annually to $9.8 billion by 2029. [1]

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

MARCH 3, 2020

MÜV EXTRACT INHALERS, ORAL SPRAYS, AND TINCTURES | Pensacola, Florida Grand Opening, February 15, 2020. Hot coffee, friendly staff, and medical cannabis eagerly greet patients and guests on Feburary 15, 2020 at the Grand Opening of MÜV Dispensary on Ninth Avenue in Pensacola, Florida. . AUTHOR: Heather Allman. Education is key.”

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

Cannabis Law Report

SEPTEMBER 15, 2021

Total retail sales in Missouri are expected to grow to USD$650 million by 2025 per New Frontier Data. The state of Missouri surpassed 100,000 patients in May 2021 (seven months after the first sale) and robust patient adoption trends have continued since. market in Missouri. market in Missouri. expansion.”.

Events 52

Events Dispensary Extraction Cannabis 52

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. authorizes home delivery to patients. authorizes home delivery to patients. Ability to meet the overall health needs of qualified patients and safety of the public.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. authorizes home delivery to patients. authorizes home delivery to patients. Ability to meet the overall health needs of qualified patients and safety of the public.

Law 40

Law Marijuana Education Cultivation 40

CannaTech

OCTOBER 14, 2018

The bill, scheduled to take effect on January 1, 2019, allows California farmers to enter the rapidly-growing hemp industry on a wide scale, raising industrial hemp to produce hemp seed, oil, fiber, and extract for a variety of uses. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

AUGUST 19, 2019

The recent trend towards decriminalization of cannabis in other countries suggests they may be right, but in the meantime, a proliferation of products containing extracts from cannabis plants are appearing in UK stores. No data is available regarding prescriptions written in respect of secondary care. Novel Foods Regulation.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Healer

APRIL 5, 2021

CBD 10 mg daily did not improve outcomes in patients suffering from Crohn’s disease.[3]. CBD 50-150 mg twice daily was effective in the treatment of chronic pain associated with kidney transplantation in 6 of 7 patients during an open-label trial.[5]. In patients with fibromyalgia, a single inhalation of CBD 18.4 CBD for Cancer.

CBD 98

CBD Chronic Pain Oil Topical 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. or less. (THC

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. The following figures are extracts from the Condensed Interim Consolidated Financial Statements and should be read in conjunction with the Condensed Interim Consolidated Financial Statements and Notes for the period ended 30 June 2021.

Business 105

Business Research and Development Environment Food 105

Green Relief

MARCH 25, 2018

What makes CBD even more desirable for some patients is that it does not cause the psychoactive effects associated with tetrahydrocannabinol (THC). The study demonstrated that a whole plant extract, containing the entire range of cannabinoids present in raw cannabis, will continue to provide relief for inflammation as the dose is increased.

Extraction 41

Extraction CBD Cannabinoids Strains 41

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. Remember, the pharmaceutical model is “this medicine addresses this specific target.” I have used it in some of my patients with autism.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Healer

APRIL 5, 2021

CBD 10 mg daily did not improve outcomes in patients suffering from Crohn’s disease.[3]. CBD 50-150 mg twice daily was effective in the treatment of chronic pain associated with kidney transplantation in 6 of 7 patients during an open-label trial.[5]. In patients with fibromyalgia, a single inhalation of CBD 18.4

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

CBD 10 mg daily did not improve outcomes in patients suffering from Crohn’s disease.[3]. CBD 50-150 mg twice daily was effective in the treatment of chronic pain associated with kidney transplantation in 6 of 7 patients during an open-label trial.[5]. In patients with fibromyalgia, a single inhalation of CBD 18.4

CBD 52

CBD Chronic Pain Oil Topical 52

SpeedWeed

JULY 8, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

Cannabis Law Report

JULY 19, 2021

Halo is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures, and distributes quality cannabis flower, oils, and concentrates and has sold approximately nine million grams of oils and concentrates since inception. 2 All sales figures sourced from the May 2021 BDSA Sales Data.

Collective 105

Collective Data Cultivation Events 105

Cannabis Law Report

JANUARY 9, 2019

Phoenix are conducting short-term CBD oil studies with local patients at the country’s general hospital. We are working with governments on single-payer healthcare systems as they are the ones who save the money, and the patients get the great end result.”. Photo: Google Maps. It’s all about access and education,” said Tindall.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

SpeedWeed

JULY 8, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52